跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
TGA
/
DAPAGLICIP dapagliflozin (as propanediol monohydrate) 10 mg film-coated tablet bottle
Approved
STANDARD
DAPAGLICIP dapagliflozin (as propanediol monohydrate) 10 mg film-coated tablet bottle
Cipla Australia Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 29, 2025
Approval ID
d4571a440760e44f
Company
Cipla Australia Pty Ltd
Type
Standard
Approval Details
Approval Id
d4571a440760e44f
Product Name
DAPAGLICIP dapagliflozin (as propanediol monohydrate) 10 mg film-coated tablet bottle
Artg Id
369310
Artg Name
DAPAGLICIP dapagliflozin (as propanediol monohydrate) 10 mg film-coated tablet bottle
Sponsor
Cipla Australia Pty Ltd
Company Detail Path
/organization/cipla-australia-pty-ltd
Artg Date
2022-03-30
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 29, 2025
Approval ID
d4571a440760e44f
Type
Standard
Back to TGA Approvals
DAPAGLICIP dapagliflozin (as propanediol monohydrate) 10 mg film-coated tablet bottle - TGA Drug Approval Details
